Carcinoembryonic antigen peptide

SKU: orb1296677

Description

CEA peptide (YLSGANLNL) is a nine-amino acid sequence derived from the carcinoembryonic antigen (CEA), a glycoprotein tumor marker. This peptide is utilized in immunological research, including in vitro T-cell stimulation assays and in vivo studies investigating anti-tumor immune responses targeting CEA-expressing cancers.

Research Area

Immunology & Inflammation

Key Properties

• Target: Others
• CAS Number: 168635-85-6
• MW: 964.07
• Purity: >99.99% (May vary between batches)
• Formula: C₄₃H₆₉N₁₁O₁₄
• SMILES: CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

CEA peptide, Carcinoembryonic Antigen (CEA), Carcinoembryonic Antigen CEA, Inhibitor, inhibit

Compound Identifiers

PubChem CID

10306739